The NF2 gene: elucidation of tumor suppressor function
NF2基因:阐明肿瘤抑制功能
基本信息
- 批准号:6648978
- 负责人:
- 金额:$ 4.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-05-01 至 2005-04-30
- 项目状态:已结题
- 来源:
- 关键词:biological signal transduction cell proliferation genetic models laboratory mouse neoplasm /cancer genetics nerve /myelin protein neurofibromatosis phosphorylation postdoctoral investigator protein isoforms protein protein interaction protein structure function serine threonine protein kinase tumor suppressor proteins
项目摘要
DESCRIPTION (provided by applicant): Neurofibromatosis type 2 (NF2) is an inherited disorder characterized by development of Schwann cell tumors of the eighth cranial nerve. The NF2 gene codes for a protein highly related to the ERM proteins moesin, ezrin and radixin and was thus termed merlin. The ERM proteins are thought to function as cell membrane-cytoskeleton linkers. Merlin is regulated, at least in part, by Rac/cdc42-dependent phosphorylation. Recent data implicates merlin as a possible negative regulator of the Rac/cdc42 signaling pathway. The proposed project focuses on the study of the tumor suppressive properties of merlin and the signaling pathways connecting extracellular signals to cytoskeletal organization and/or the proliferative state of the cell, via merlin. The work involves two combined approaches: 1) Understanding how merlin might interact with and regulate, the Rac/cdc42 signaling pathway. 2) Structure/function studies of merlin involving introduction of isoforms and mutated forms of the protein into Nf2-deficient cells. Specifically, mutations effecting merlin phosphorylation will be examined. The proposed project should shed light on the growth suppressive effects of merlin and possible cross-talk with the Rac/cdc42 pathway. This should lead to a better understanding of merlin function in normal cells and the consequences of its loss in tumor development. Such information will directly assist in the search for effective therapies.
描述(申请人提供):神经纤维瘤病2型(NF2)是一种遗传性疾病,其特征是发展为第八脑神经的雪旺细胞瘤。NF2基因编码一种与ERM蛋白moesin、ezrin和Radixin高度相关的蛋白质,因此被称为Merlin。ERM蛋白被认为是细胞膜-细胞骨架连接物。Merlin至少部分受RAC/Cdc42依赖的磷酸化调控。最近的数据表明,Merlin可能是RAC/CDC42信号通路的负调控因子。该项目的重点是研究Merlin的肿瘤抑制特性,以及通过Merlin将细胞外信号与细胞骨架组织和/或细胞增殖状态联系起来的信号通路。这项工作涉及两个结合的方法:1)了解Merlin可能如何与RAC/CDC42信号通路相互作用和调节。2)Merlin的结构/功能研究,包括将该蛋白的异构体和突变形式导入NF2缺陷细胞。具体地说,将检测影响Merlin磷酸化的突变。拟议的项目应该有助于阐明Merlin对生长的抑制作用,以及可能与RAC/CDC42途径的相互作用。这应该有助于更好地理解Merlin在正常细胞中的功能以及它在肿瘤发展过程中丢失的后果。这些信息将直接帮助寻找有效的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH KISSIL其他文献
JOSEPH KISSIL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH KISSIL', 18)}}的其他基金
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
- 批准号:
10473771 - 财政年份:2021
- 资助金额:
$ 4.81万 - 项目类别:
Employing functionalized fragment libraries to identify therapeutic agents for neurofibromatosis type 2
利用功能化片段库来鉴定 2 型神经纤维瘤病的治疗药物
- 批准号:
10401628 - 财政年份:2021
- 资助金额:
$ 4.81万 - 项目类别:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
- 批准号:
10680527 - 财政年份:2021
- 资助金额:
$ 4.81万 - 项目类别:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
- 批准号:
10211400 - 财政年份:2021
- 资助金额:
$ 4.81万 - 项目类别:
Employing functionalized fragment libraries to identify therapeutic agents for neurofibromatosis type 2
利用功能化片段库来鉴定 2 型神经纤维瘤病的治疗药物
- 批准号:
10704416 - 财政年份:2021
- 资助金额:
$ 4.81万 - 项目类别:
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
CARM1 介导的 YAP1 调节作为肺癌的治疗靶点
- 批准号:
10391561 - 财政年份:2020
- 资助金额:
$ 4.81万 - 项目类别:
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
CARM1 介导的 YAP1 调节作为肺癌的治疗靶点
- 批准号:
10613467 - 财政年份:2020
- 资助金额:
$ 4.81万 - 项目类别:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
- 批准号:
10201375 - 财政年份:2020
- 资助金额:
$ 4.81万 - 项目类别:
相似海外基金
EFR3: Novel gatekeeper of cell proliferation
EFR3:细胞增殖的新型看门人
- 批准号:
DP240102729 - 财政年份:2024
- 资助金额:
$ 4.81万 - 项目类别:
Discovery Projects
Modulation of cell proliferation by the tumor suppressor protein NRK
肿瘤抑制蛋白 NRK 对细胞增殖的调节
- 批准号:
23K08817 - 财政年份:2023
- 资助金额:
$ 4.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MR imaging for the cell proliferation using in vivo click chemistry
使用体内点击化学进行细胞增殖的 MR 成像
- 批准号:
23K18279 - 财政年份:2023
- 资助金额:
$ 4.81万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Project 1: Determine the mechanisms Cyclin D-Cdk4/6 uses to drive cell proliferation
项目 1:确定 Cyclin D-Cdk4/6 驱动细胞增殖的机制
- 批准号:
10867552 - 财政年份:2023
- 资助金额:
$ 4.81万 - 项目类别:
Identification of active components of sillkworm serum exhibiting cell proliferation and elucidation of the mechanism
蚕血清中细胞增殖活性成分的鉴定及其机制的阐明
- 批准号:
23KJ1691 - 财政年份:2023
- 资助金额:
$ 4.81万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The Role of Arginine Transport on Pancreatic Alpha Cell Proliferation and Function
精氨酸转运对胰腺α细胞增殖和功能的作用
- 批准号:
10678248 - 财政年份:2023
- 资助金额:
$ 4.81万 - 项目类别:
Regulation of Adherent Cell Proliferation by Matrix Viscoelasticity
基质粘弹性对贴壁细胞增殖的调节
- 批准号:
10735701 - 财政年份:2023
- 资助金额:
$ 4.81万 - 项目类别:
Mechanisms of cell proliferation in whole-genome doubled cells
全基因组加倍细胞的细胞增殖机制
- 批准号:
10467183 - 财政年份:2022
- 资助金额:
$ 4.81万 - 项目类别:
mechanism of cancer cell proliferation in bone microenvironment of renal cell carcinoma
肾细胞癌骨微环境中癌细胞增殖机制
- 批准号:
22K09370 - 财政年份:2022
- 资助金额:
$ 4.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
mRNA selective translational control required for B cell proliferation
B 细胞增殖所需的 mRNA 选择性翻译控制
- 批准号:
2757728 - 财政年份:2022
- 资助金额:
$ 4.81万 - 项目类别:
Studentship